BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 21866101)

  • 1. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection.
    Côté M; Misasi J; Ren T; Bruchez A; Lee K; Filone CM; Hensley L; Li Q; Ory D; Chandran K; Cunningham J
    Nature; 2011 Aug; 477(7364):344-8. PubMed ID: 21866101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection.
    Shoemaker CJ; Schornberg KL; Delos SE; Scully C; Pajouhesh H; Olinger GG; Johansen LM; White JM
    PLoS One; 2013; 8(2):e56265. PubMed ID: 23441171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Small Molecule Entry Inhibitors of Ebola Virus.
    Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.
    Carette JE; Raaben M; Wong AC; Herbert AS; Obernosterer G; Mulherkar N; Kuehne AI; Kranzusch PJ; Griffin AM; Ruthel G; Dal Cin P; Dye JM; Whelan SP; Chandran K; Brummelkamp TR
    Nature; 2011 Aug; 477(7364):340-3. PubMed ID: 21866103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filoviruses Use the HOPS Complex and UVRAG To Traffic to Niemann-Pick C1 Compartments during Viral Entry.
    Bo Y; Qiu S; Mulloy RP; Côté M
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step.
    Mingo RM; Simmons JA; Shoemaker CJ; Nelson EA; Schornberg KL; D'Souza RS; Casanova JE; White JM
    J Virol; 2015 Mar; 89(5):2931-43. PubMed ID: 25552710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by
    Mittler E; Alkutkar T; Jangra RK; Chandran K
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway.
    Spence JS; Krause TB; Mittler E; Jangra RK; Chandran K
    mBio; 2016 Feb; 7(1):e01857-15. PubMed ID: 26861015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1.
    Ng M; Ndungo E; Jangra RK; Cai Y; Postnikova E; Radoshitzky SR; Dye JM; Ramírez de Arellano E; Negredo A; Palacios G; Kuhn JH; Chandran K
    Virology; 2014 Nov; 468-470():637-646. PubMed ID: 25310500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection
    Kummer S; Lander A; Goretzko J; Kirchoff N; Rescher U; Schloer S
    Emerg Microbes Infect; 2022 Dec; 11(1):195-207. PubMed ID: 34919035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments.
    Stewart CM; Phan A; Bo Y; LeBlond ND; Smith TKT; Laroche G; Giguère PM; Fullerton MD; Pelchat M; Kobasa D; Côté M
    PLoS Pathog; 2021 Jan; 17(1):e1009275. PubMed ID: 33513206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential pharmacological strategies targeting the Niemann-Pick C1 receptor and Ebola virus glycoprotein interaction.
    Morales-Tenorio M; Ginex T; Cuesta-Geijo MÁ; Campillo NE; Muñoz-Fontela C; Alonso C; Delgado R; Gil C
    Eur J Med Chem; 2021 Nov; 223():113654. PubMed ID: 34175537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection.
    Nelson EA; Dyall J; Hoenen T; Barnes AB; Zhou H; Liang JY; Michelotti J; Dewey WH; DeWald LE; Bennett RS; Morris PJ; Guha R; Klumpp-Thomas C; McKnight C; Chen YC; Xu X; Wang A; Hughes E; Martin S; Thomas C; Jahrling PB; Hensley LE; Olinger GG; White JM
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005540. PubMed ID: 28403145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
    Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies.
    Bornholdt ZA; Ndungo E; Fusco ML; Bale S; Flyak AI; Crowe JE; Chandran K; Saphire EO
    mBio; 2016 Feb; 7(1):e02154-15. PubMed ID: 26908579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Cell-Cell Fusion by Ebola Virus Glycoprotein: Low pH Is Not a Trigger.
    Markosyan RM; Miao C; Zheng YM; Melikyan GB; Liu SL; Cohen FS
    PLoS Pathog; 2016 Jan; 12(1):e1005373. PubMed ID: 26730950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.
    Martinez O; Ndungo E; Tantral L; Miller EH; Leung LW; Chandran K; Basler CF
    J Virol; 2013 Mar; 87(6):3324-34. PubMed ID: 23302883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry.
    Fels JM; Spence JS; Bortz RH; Bornholdt ZA; Chandran K
    mBio; 2019 Jul; 10(4):. PubMed ID: 31289183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-based design of peptide entry inhibitors targeting the endosomal receptor binding site of filoviruses.
    Wang LL; Estrada L; Wiggins J; Anantpadma M; Patten JJ; Davey RA; Xiang SH
    Antiviral Res; 2022 Oct; 206():105399. PubMed ID: 36007601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.
    Zhang X; Ao Z; Bello A; Ran X; Liu S; Wigle J; Kobinger G; Yao X
    Antiviral Res; 2016 Mar; 127():20-31. PubMed ID: 26778707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.